Targeted therapies for solid tumors: current status and future perspectives

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Archontoula Stoffel

Abstract

The therapeutic benefits of targeted clinical interventions with increased selectivity and fewer adverse effects hold great promise in the treatment of solid malignancies, both in monotherapy and in combination. Molecular targeted therapies offer increasingly customized solutions based on the targeting of multiple specific pathways essential for cancer development and metastasis, allowing the maintenance of quality of life while efficiently attacking the tumor. To date, several monoclonal antibodies (mAbs) and small-molecule inhibitors have been approved for the treatment of colorectal, breast, head and neck, non-small cell lung and renal cell cancer. A number of additional targeted therapies are currently being investigated in ongoing clinical trials in various tumor types such as lung, gastric, cervical, uterine melanoma, and brain tumors. This article describes current and newly developed targeted therapies in solid tumors, with a special focus on tyrosine kinase inhibitors. These include mAbs and small-molecule inhibitors that aim to specifically disrupt receptor signaling pathways, which are essential for proliferation, survival and migration of tumor cells.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 20, 2001·Critical Reviews in Oncology/hematology·X D YangC G Davis
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonM E Harper
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Baselga
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Mar 1, 2002·The New England Journal of Medicine·David G Savage, Karen H Antman
Jun 28, 2002·Cancer Cell·Kari Alitalo, Peter Carmeliet
Nov 5, 2002·Nature Reviews. Cancer·Shahin RafiiBeate Heissig
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Dec 6, 2003·The Oncologist·Gordana Vlahovic, Jeffrey Crawford
Dec 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G SelvaggiG V Scagliotti
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H JohnsonFairooz Kabbinavar
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Dec 2, 2004·Nature Reviews. Cancer·Roy S HerbstJosé Baselga
Jan 5, 2005·Nature Reviews. Cancer·Bruce A Chabner, Thomas G Roberts
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy D MillerHope S Rugo
May 3, 2005·Nature Reviews. Cancer·Nancy E Hynes, Heidi A Lane
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstUNKNOWN TRIBUTE Investigator Group
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara BurtnessUNKNOWN Eastern Cooperative Oncology Group
Jan 21, 2006·Nature Reviews. Drug Discovery·David SchramaJürgen C Becker
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Apr 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark J RatainPeter J O'Dwyer
Aug 3, 2006·Nature Reviews. Drug Discovery·Sandrine FaivreEric Raymond
Aug 18, 2006·Nature Reviews. Cancer·David M Sabatini
Aug 25, 2006·Nature Reviews. Cancer·Kohzoh Imai, Akinori Takaoka
Oct 27, 2006·Expert Opinion on Emerging Drugs·Roy S Herbst
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Dec 29, 2006·The New England Journal of Medicine·Charles E GeyerDavid Cameron
Jan 4, 2007·Nature Reviews. Drug Discovery·Leonard SaltzPeter Kirkpatrick
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce J GiantonioUNKNOWN Eastern Cooperative Oncology Group Study E3200

❮ Previous
Next ❯

Citations

Aug 16, 2012·Pediatric Surgery International·K K Y Wong, X L Liu
Mar 16, 2011·Apoptosis : an International Journal on Programmed Cell Death·Vincenzo GiansantiA Ivana Scovassi
Aug 2, 2012·Clinical & Experimental Metastasis·Jessica R Newton-NorthupSusan L Deutscher
Mar 12, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jibin YaoYongbin Zhang
Sep 29, 2011·Seminars in Cancer Biology·Anna M AzarovaRani E George
Jun 29, 2011·The Journal of Molecular Diagnostics : JMD·Mark G ErlanderCatherine A Schnabel
Jun 28, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Iris Eke, Nils Cordes
Sep 19, 2017·Cellular Oncology (Dordrecht)·Meysam YousefiSeyed H Ghaffari
Nov 13, 2019·Applied Biochemistry and Biotechnology·Nivya JamesK Ramanathan
May 10, 2017·Cell Biochemistry and Biophysics·Nivya James, K Ramanathan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Daniel ZipsMichael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Maud H W StarmansPhilippe Lambin
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Camilla Molich HoffJens Overgaard
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Erika MartinelliFortunato Ciardiello
© 2021 Meta ULC. All rights reserved